CASP9 and cerebral infarction: Piperine improved behavioral performance; reduced cellular damage, areas of cerebral infarction, and major macro- and micro-cellular cerebral structural changes; inhibited BAX; decreased caspase-3, caspase-9, and cytochrome-c expression; and increased Bcl-2 expression